TeleHealth Resistance Exercise Intervention to Preserve Dose Intensity and Vitality in Elder Breast Cancer Patients
Part of paid clinical trials in Boston, Massachusetts.
- Sponsor
- Dana-Farber Cancer Institute
- Study ID
- NCT05535192
- Status
- Recruiting
Conditions
- Breast Cancer
- Breast Cancer Female
- Stage I Breast Cancer
- Stage II Breast Cancer
- Stage III Breast Cancer
Eligibility Criteria
- Sex
- FEMALE
- Age
- 65 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- THRIVE — BEHAVIORALThe THRIVE Intervention will involve: 1\) one in-person exercise sessions, followed by twice-weekly, home-based exercise sessions, supervised remotely through telehealth, and 2) a remotely delivered dietary assessment and recommendations to support protein intake throughout the study
- Health Education Support Program — BEHAVIORALParticipants will receive a tablet with information and resources regarding mediation, stretching and gentle movement, relaxation and creative arts during chemotherapy
Study Details
This research is being done to assess whether an exercise intervention with protein intake support vs a health education and support program will make it easier for women age 65 or older who are receiving chemotherapy for breast cancer to receive all of their planned chemotherapy according to schedule and at the planned dose.
Key Dates
- Start date
- Mar 20, 2023
- Status verified
- Apr 2026
- Primary completion
- Sep 30, 2026
- Completion
- Feb 1, 2027
Study Design
- Enrollment
- 270 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- SUPPORTIVE_CARE
Arms
- Active Comparator: HEALTH EDUCATION AND SUPPORT CONTROL GROUPThe research study procedures include screening for eligibility and a baseline visit to collect measurements and questionnaires. After the baseline appointment, participants randomized into the Heath Education Support Program will receive a tablet from the study that is pre-loaded with material to help support them during chemotherapy. The tablet materials will include supportive care and resources that focus on movement (light stretching and gentle yoga), soothing music, meditation/mindfulness, and recipes/cooking demos. Participants in this arm will be asked to fill out questionnaires at the start of each chemotherapy cycle to indicate any side effects from chemotherapy and the amount of time they spend engaging with the tablet. At the end of participants' chemotherapy, they will be asked to complete end-of-study measures.
- Experimental: THRIVE: EXERCISE INTERVENTION WITH PROTEIN INTAKE SUPPORTThe research study procedures include screening for eligibility and a baseline visit to collect measurements and questionnaires. After the baseline appointment, participants randomized into the THRIVE Exercise and Diet Intervention will work with a coach to gradually build exercise and stay active during chemotherapy treatment. Participants will work with an exercise coach to reach the muscle strengthening and aerobic exercise goals of the study. Participants will also consult with a dietician to ensure adequate protein intake during the study. Participants in this arm will be asked to fill out questionnaires at the start of each chemotherapy cycle to indicate any side effects from chemotherapy. At the end of participants' chemotherapy, they will be asked to complete end-of-study measures.
Primary Outcome Measure
Received Dose Intensity (RDI) [ Time Frame: Baseline to 26 weeks ]
Central Contacts
- Kathryn Schmitz, PhD, MPH412-623-6216
- Jennifer Ligibel, MD617-632-3800
Locations (3)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Dana Farber Cancer Institute | Boston | Massachusetts | 02215 | Jennifer Ligibel, MD (PRINCIPAL_INVESTIGATOR) |
| Case Western Reserve University/University Hospitals Cleveland | Cleveland | Ohio | 44106 | Nathan Berger, MD Cynthia Owusu, MD |
| University of Pittsburgh | Pittsburgh | Pennsylvania | 15232 |
Find similar trials in Boston, MA
By condition
By specialty
Related Studies
- I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast CancerPHASE2 · Recruiting · QuantumLeap Healthcare Collaborative · Birmingham, Alabama
- Proteomics and Radiomics Research of Breast Cancer Markers in Tissue, Interstitial Fluid and SerumRecruiting · University of Pittsburgh · Pittsburgh, Pennsylvania
- Cardiotoxicity of Cancer Therapy (CCT)Enrolling By Invitation · Abramson Cancer Center at Penn Medicine · Philadelphia, Pennsylvania
- Integrated Cancer Repository for Cancer ResearchRecruiting · University of Nebraska · Greenwood Village, Colorado